SBI Securities’s Oragenics OGEN Stock Holding History

SBI Securities’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13	Buy	23 +12	+109%	+$7	﹤0.01%	3902
2026 Q1	$6	Buy	11 +1	+10%	+$1	﹤0.01%	3902
2025 Q4	$8	Hold	10	–	–	﹤0.01%	3895
2025 Q3	$13	Hold	10	–	–	﹤0.01%	3992
2025 Q2	$38	Buy	10 +9	+900%	+$46	﹤0.01%	3781
2025 Q1	$6	Hold	1	–	–	﹤0.01%	4018
2024 Q4	$11	Buy	+1	New	+$10	﹤0.01%	3924

Other funds holding OGEN

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SJIM

St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ASCM

Adkins Seale Capital Management Shreveport, Louisiana $112M AUM

SBI Securities's OGEN Position: Q2 2026 in Review

SBI Securities increased its Oragenics (OGEN) stake by 109% in Q2 2026, buying an estimated $7 and bringing the position to 23 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #3902.

SBI Securities first reported a position in OGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $38 in Q2 2025. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

SBI Securities held 23 shares of Oragenics worth $13 as of Q2 2026.
SBI Securities bought 12 Oragenics shares in Q2 2026, an estimated $7.
Oragenics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3902 holding.
SBI Securities first reported a position in Oragenics in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Oragenics position peaked at $38 in Q2 2025.
17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.